2018
DOI: 10.3892/ijmm.2018.3457
|View full text |Cite
|
Sign up to set email alerts
|

Long noncoding RNA ENSRNOG00000037522 is involved in the podocyte epithelial‑mesenchymal transition in diabetic rats

Abstract: Diabetic nephropathy (DN) is one of the most common complications associated with type I and II diabetes mellitus. Long noncoding RNAs (lncRNAs) have been implicated in various physiological and pathological processes, and recent evidence has demonstrated that they are involved in the process of the epithelial-mesenchymal transition (EMT). In the present study, the potential functions of lncRNA ENSRNOG00000037522 during the EMT process in DN were investigated. The results identified that the level of the lncRN… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
18
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(20 citation statements)
references
References 47 publications
(51 reference statements)
2
18
0
Order By: Relevance
“…For example, lncRNA ENSRNOG00000037522 is involved in the J Cell Physiol. 2019;234:12926-12933. wileyonlinelibrary.com/journal/jcp podocyte EMT process in diabetic rats (Ling et al, 2018). LncRNA CYP4B1-PS1-001 can regulate the proliferation and fibrosis in DN .…”
Section: Introductionmentioning
confidence: 99%
“…For example, lncRNA ENSRNOG00000037522 is involved in the J Cell Physiol. 2019;234:12926-12933. wileyonlinelibrary.com/journal/jcp podocyte EMT process in diabetic rats (Ling et al, 2018). LncRNA CYP4B1-PS1-001 can regulate the proliferation and fibrosis in DN .…”
Section: Introductionmentioning
confidence: 99%
“…Long et al (8) reported that Tug1 regulates mitochondrial function in podocytes by the epigenetic targeting of the transcription factor peroxisome proliferator-activated receptor ␥ coactivator 1␣. Ling et al (9) showed that lncRNA ENSRNOG00000037522 is involved in the podocyte epithelial-mesenchymal transition in diabetic rats.…”
mentioning
confidence: 99%
“…Many studies have reported relationships between lncRNAs and DN. For instance, overexpression of the lncRNAs ENSMUST00000147869 and cytochrome P450, family 4, subfamily b, polypeptide 1, pseudogene 1 (CYP4B1-PS1-001) was reported to inhibit the proliferation and fibrosis of mouse MCs in DN (26,27); the lncRNAs myocardial infarction associated transcript (MIAT) and plasmacytoma variant translocation 1 (Pvt1) were reported to regulate renal tubular epithelial injury and ECM accumulation in DN (28,29); silencing of the lncRNAs ENSRNOG00000037522 and long intergenic non-protein coding RNA 1619 (LINC01619) was reported to partially restore podocyte damage in DN (30,31); silencing of the lncRNA erb-b2 receptor tyrosine kinase 4-IR9 (Erbb4-IR9) prevented kidney damage and fibrosis in DN via miR-29b (32); the lncRNA Gm4419 affected DN mesangial proliferation by binding to the subunit P50 of NF-kB (33); and the lncRNA Pvt1 was reported to contribute to susceptibility to DN through a genome-wide analysis of single-nucleotide polymorphisms (34). Thus, these results suggest that lncRNAs play important roles in the pathogenesis of DN.…”
Section: Discussionmentioning
confidence: 99%